Meeting report – Expert meeting on drug-related infectious diseases (DRID) 2020

This meeting report provides an overview of the content of the DRID meeting that took place online on 22-23 October 2020, focusing on:

• the direct and indirect impact of COVID-19 on drug users and harm reduction services involved in HIV, hepatitis and STI prevention, care and treatment;
• an assessment of the progress made towards the Sustainable Development Goals (SDG) and corresponding targets for HIV and viral hepatitis among people who inject drugs (PWID), with a focus on HBV vaccination and HCV continuum of care;
• a review of recent HIV and HCV outbreaks linked to injecting drug use with a focus on detection, risk factors and control measures;
• a methodological review of two monitoring tools: city-level respondent-driven sampling studies and continuous monitoring systems in drug services.